Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Johnson & Johnson (NYSE: JNJ)

$125.48 USD -$0.42 (-0.33%)
Last Price $125.48
Net Change $-0.42 (-0.33%)
Bid $0
Ask Price $0
Open Price $125.86
Previous Close Price $125.9
High Price $126.36
Low Price $125.13
Number of Trades 28,510
Volume 6,490,300
Fifty Two Week High $129 (2017-03-15)
Fifty Two Week Low $107.69 (2016-04-01)
Average Daily Volume 7,351,667
Share Outstanding 2,710,890 Shares
Total Dividend Payout 3.2/yr
Dividend Yield 2.54%
1st Quarter Earnings $1.58 (2017-01-24)
2nd Quarter Earnings $1.68 (2016-10-18)
3nd Quarter Earnings $1.74 (2016-07-19)
4th Quarter Earnings $1.68 (2016-04-19)
PE Ratio $18.85
EPS Growth $4.18
Recent Earnings $1.58
Annual EPS $6.68
Last Quarter EPS $
Market Capitalization $340.16B
Insider Shareholders % 0.0019%
Annual Revenue $0B
No. Shares Outstanding 2,710,890
Inst. Shareholder % 66.12%
Annual Net Income $16.38B
TTM Net Profit Margin $23.01
1-Year Return 19.14%
3-Year Return 40.6%
5-Year Return 123.35%
5-Year Revenue Growth 10.55%
5-Year Earnings Growth 34.6%
5-Year Dividend Growth 40%
Annual Dividend $3.2
Annual Dividend Yield 2.54%
Change in EPS YTD 4.18%
Dividends per Share $0.8
Stock Split Ratio 2-1
Beta 0.79
Johnson & Johnson is engaged in the research and development manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer Pharmaceutical and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care skin care oral care wound care and women's health fields nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective antipsychotic contraceptive dermatology gastrointestinal hematology immunology neurology oncology pain management thrombosis vaccines and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction spinal care neurological and sports medicine products; surgical care aesthetics and women's health products. Johnson & Johnson is based in New Brunswick New Jersey.

Today's Johnson & Johnson Stock Update

While we usually like to analyze for investors whether a stock is a buy or not, we also like to give you a quick rundown of the Johnson & Johnson stock information you need today, with key data on recent JNJ moves. That's what you can get right here. We'll start with where JNJ ended trading yesterday -- at a share price of $125.48. Johnson & Johnson shares dropped 0.33% or $0.42 from the day before. Here's how the current Johnson & Johnson stock price level compares to recent highs and lows... The Johnson & Johnson stock price is at a higher price than it was last year at this time, with the stock price up 15.85%.

BREAKING: How a 26(f) Program Can Save Your Retirement

The Johnson & Johnson stock price 52-week high is $129.00. That was hit on 3/15/2017. The JNJ stock 52-week low is $107.69, reached on 4/01/2016. Also - JNJ trading volume yesterday was 8,508,000. That's greater than Johnson & Johnson stock's average daily trading volume of 6,502,304. The market cap of Johnson & Johnson is 340,162,477,000. That means Johnson & Johnson has a mega market cap, because it's over 200 billion. As of April 1, 2016, the company with the biggest market cap of all publicly traded companies is Apple.

TRENDING: The Best Stocks to Buy Now

The current P/E (price/earnings) ratio of Johnson & Johnson stock is 18.90. That's not as high as the March 2016 S&P 500 P/E ratio of about 23. To really gauge if this stock's P/E is high or low, you should compare JNJ to other companies in the same industry. The current EPS (earnings per share) of JNJ is 5.88. Beta - how closely the stock trades with the overall market, with a beta of 1 meaning it trades in step with the broader index -- for Johnson & Johnson is 0.79. Johnson & Johnson stock has a dividend yield of 2.54%. Generally a dividend yield of 2% or more is decent for those investors who want income from dividend stocks. Money Morning gives you Johnson & Johnson stock news daily. We publish new info on JNJ and dozens of other key companies we're watching now, every day, so investors will never miss an opportunity. As always, our content is free.

UP NEXT: These Are the Top 5 Marijuana Stocks to Watch in 2017 - Don't Miss This Sector's Staggering Profit Potential

Click here to read more stories